Women's healthcare vendor Hologic of Bedford, MA, has entered into a definitive agreement to acquire Canadian breast MRI technology developer Sentinelle Medical of Toronto for $85 million.
The transaction is expected to close in the third calendar quarter and is subject to customary closing conditions, including that of Sentinelle Medical's stockholders and Canadian judicial approval.
Sentinelle Medical develops breast imaging technologies using high-field-strength MRI designed for the early detection of breast cancer, as well as patient tables and visualization software. In 2009, Sentinelle Medical achieved revenues of approximately $15 million.
Hologic President and CEO Rob Cascella said the acquisition advances the company's strategy and portfolio in women's healthcare, especially in breast cancer detection and intervention, and broadens Hologic's presence in women's health by offering additional products through existing sales channels.
Related Reading
Hologic's Selenia nets EUREF certification, June 23, 2010
Hologic posts Q2 revenue gain, May 4, 2010
Hologic debuts upright biopsy at ECR, March 8, 2010
Sentinelle touts breast MRI coils, December 1, 2009
Sentinelle, Ultrasonix partner on new system, November 30, 2009
Sentinelle signs deal with Calgary Scientific, June 5, 2009
Copyright © 2010 AuntMinnie.com
